Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases?

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 3, 2013, Pages 791-804

  Bellussi, L M ^a   Iosif, C ^b   Sarafoleanu, C ^b,c   Jianu, E ^b,c   Duda, R ^b,c   Panaitescu, E ^c   Passali, F M ^d   Passali, D ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Sfanta Maria Hospital Bucharest   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Allergy; ASA intolerance; Chronic rhinosinusitis; HMGB1 protein; Nasal polyposis; Upper airways inflammation

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CELL NUCLEUS; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY INFILTRATE; INTERCELLULAR SPACE; MALE; NOSE POLYP; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RESPIRATORY TRACT INFLAMMATION; CHRONIC DISEASE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY; SINUSITIS; NASAL POLYPS; RHINITIS, ALLERGIC, PERENNIAL;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS; RHINITIS, ALLERGIC;

EID: 84891590107     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bustin M, Hopkins RB, Isenberg I. Immunological relatedness of high-mobility group chromosomal proteins from calf thymus. J Biol Chem 1978; 2531694-9.
2. Verrijdt G, Haelens A, Schoenmaker E, Rombauts W, Claessens F. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem J 2002; 361:97-103.
3. Park JS. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279:7370-7.
4. Scaffidi P, Misteli B, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-5.
5. Gardella S, Andrei C, Ferrera D, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vescicle-mediated secretory pathway. EMBORep 2002;3:995-1001.
6. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AR Inflammation promoting activity of HMGB1 of human microvascular endothelial cells. Blood 2003; 101:2652-60.
7. Lotze MT, Tracey KJ. High-mobility group box 1 protein(HMGB1):nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5:331-42.
8. Bianchi ME, Manfredi AA. High-mobility group box 1 protein (HMGB1) at the crossroad between innate and adaptive immunity. Immunol Rev 2007; 220:35-46.
9. Han SH, Kim YH, Mook-Jung I. RAGE: the beneficial and deleterious effects by diverse mechanisms of action. Mol Cells. 2011 Feb; 31(2):91-7.
10. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-51.
11. WittemannB, Neuer G, Michels H, Truckenbrodt H, Bautz F. Autoantibodies to nonhistone chromosomal protein HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis Arthritis Rheum. 1990; 33:1378-83.
12. Ayer LM, Rubin RL, Dixon GH, Fritzler MJ. Antibodies to HMG proteins in patients with drug-induced autoimmunity. Arthritis Rheum 1994; 37:98-103.
13. Evans A, Lennard TW, Davies BR. High-mobility group protein 1: metastasis-associated or metastasis-inducing? J Surg Oncol 2004; 88:86-99.
14. Watanabe T, Asai K, Fujimoto H, Kanazawa H, Hirata K. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 2011; 205(4):519-25.
15. Hou C, Zhao H, Liu L, et al. High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 20011; 17(7-8):807-15.
16. Zhou Y, Jang YQ, Wang WX, Zhou ZX, Wang YG, Yang L, Ji YL. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol 2012; 73(11):1171-4.
17. Passali D, Kern E, Chen L, et al. High mobility group box 1 (HMGB1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases. Acta Otorhinolaryngol Ital 2012; 32:46-7.
18. Bellussi LM, Chen L, Chen D, Passali FM, Passali D. The role of high mobility group box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngol Ital 2012; 32:386-92.
19. Lund VJ, McKay IS. Staging in rhinosinusitis. Rhinology 1993; 107:183-4.
20. Manea C, Iosif C, Sarafoleanu D. The value of histopathologic score as predictive factor in choosing the optimal surgical treatment for chronic rhinosinusitis. Romanian Journal of Rhinology 2012; 2(6):11-16.
21. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe - an underestimated disease. A GA(2)LEN study. Allergy 2011; 66(9):1216-23.
22. Leung DYM, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003; 111(1):3-22.
23. Valera FCP, Queirozw R, Scrideliw C, et al. Expression of transcription factors NF-kB and AP-1 in nasal polyposis. Clin Exp Allergy 2008; 38:579-85.
24. Sitia G, Iannacone M, Muller S, Bianchi ME, Guidotti LG. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol 2007; 81:100-7.
25. Teul I, Zbislawski W, Baran S, Czerwinski F, Lorkowski J. Quality of life of patients with diseases of sinuses. J Physiol Pharmacol 2007; 58(5Pt2):691-7.